Skip to content

Clinical trials

Completed Anemia, Refractory, with Excess of Blasts trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Status: Completed Country / region: United Kingdom Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20111
20141
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Leukemia Research Fund1
Medical Research Council1
Novartis Pharmaceuticals1
Stichting Hemato-Oncologie voor Volwassenen Nederland1
The University of New South Wales1
University Hospital Southampton NHS Foundation Trust1
University of Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts7
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Leukemia4
Congenital Abnormalities3
Leukemia, Erythroblastic, Acute3
Leukemia, Megakaryoblastic, Acute3
Leukemia, Monocytic, Acute3
Leukemia, Myelomonocytic, Acute3
Cytopenia1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.